Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_003611.3(OFD1):āc.1294A>Gā(p.Lys432Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000476 in 1,203,364 control chromosomes in the GnomAD database, including 1 homozygotes. There are 170 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
OFD1 (HGNC:2567): (OFD1 centriole and centriolar satellite protein) This gene is located on the X chromosome and encodes a centrosomal protein. A knockout mouse model has been used to study the effect of mutations in this gene. The mouse gene is also located on the X chromosome, however, unlike the human gene it is not subject to X inactivation. Mutations in this gene are associated with oral-facial-digital syndrome type I and Simpson-Golabi-Behmel syndrome type 2. Many pseudogenes have been identified; a single pseudogene is found on chromosome 5 while as many as fifteen have been found on the Y chromosome. [provided by RefSeq, Aug 2016]
Computational evidence support a benign effect (MetaRNN=0.09368104).
BP6
Variant X-13756650-A-G is Benign according to our data. Variant chrX-13756650-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 188156.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-13756650-A-G is described in Lovd as [Likely_benign].
Genetic Services Laboratory, University of Chicago
Nov 28, 2017
- -
OFD1-related disorder Benign:1
Likely benign, no assertion criteria provided
clinical testing
PreventionGenetics, part of Exact Sciences
Feb 01, 2023
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter
clinical testing
Ambry Genetics
Mar 31, 2017
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Likely benign, criteria provided, single submitter
clinical testing
CeGaT Center for Human Genetics Tuebingen
Feb 01, 2024
OFD1: BS2 -
Familial aplasia of the vermis;C1510460:Orofaciodigital syndrome I Benign:1